BetaGlue Therapeutics

Milan, Italy · Founded 2009 · Privately Held (backing)

Developer of a medical platform designed to provide a targeted approach in the treatment of cancer. BetaGlue Therapeutics is based in Milan, Italy and was founded in 2009. Its last reported valuation was $25.3 million in Jul 2022. It has raised $49 million.

Last reported valuation
$25.3M
Oct 2026
Priced at
—
Total raised
$49.0M
Last round
—

Who backs BetaGlue Therapeutics?

14 investors
InvestorType
European Innovation CouncilVenture capital
LIFTTVenture capital
NEVA SGRVenture capital
Panakes PartnersVenture capital
Enea Tech e BiomedicalOther
Petrone GroupOther
ENEA Tech Biomedical—
European Innovation Council (Belgium)—
Fin Posillipo—
Giovanni Cerutti—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BetaGlue Therapeutics investors

14 investors are on record for BetaGlue Therapeutics, including European Innovation Council, LIFTT, NEVA SGR and Panakes Partners.

Free account
More of BetaGlue Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch BetaGlue Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like BetaGlue Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View